Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATRA in Immune Thrombocytopenia
NCT04618328Phase 2Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Nov 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tretinoin in immune thrombocytopenia (ITP), sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
tretinoin
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT04618328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04618328.